老年营养风险指数 (GNRI) 与百岁老人的全因死亡率之间的关联,重点关注非线性和值效应:一项多方法观察性研究
Xuhui Liu1, Yihan Tang2, Xujie Wang3
1Department of Neurology, The Second Hospital of Lanzhou University, Lanzhou, China.
Frontiers in nutrition
|March 9, 2026
概括
老年营养风险指数 (GNRI) 与百岁老人的死亡率有关. 低于96.378的GNRI显著降低了死亡风险,这表明非常老年人营养干预的目标.
科学领域:
- 老年医学 老年医学
- 营养科学 营养科学
- 长寿研究研究 长寿研究
背景情况:
- 老年营养风险指数 (GNRI) 评估了老年人的营养状况.
- 关于GNRI与百岁老人死亡率相关的数据有限.
- 这项研究调查了100岁以上个体的GNRI和全因死亡率.
研究的目的:
- 检查老年营养风险指数 (GNRI) 与全因死亡率之间的关系.
- 确定GNRI在预测百岁老人死亡率方面的潜在值.
主要方法:
- 分析了1002名百岁老人,以死亡率为主要终点.
- 考克斯的比例危险模型和受限立方线评估了GNRI与死亡率的关联.
- 倾向性得分匹配 (PSM) 用于强大的灵敏度分析.
主要成果:
- GNRI显示了强烈的,非线性反向关联与百岁老人的死亡率.
- 在GNRI = 96.378.8时确定了死亡风险值.
- 较低的GNRI值 (<96.378) 与显著降低的死亡风险有关,PSM证实了这一发现.
结论:
- 在百岁以上的人群中,GNRI是所有原因死亡率的重要预测因素.
- 大约96.378的GNRI值可以指导营养干预.
- 这一门为极老年人个性化营养护理提供了定量目标.
相关概念视频
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
300
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
300
Pharmacodynamics in Geriatric Patients: Effects of Age
298
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
298
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
289
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
289
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
781
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
781
